These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 23163661)

  • 1. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation.
    Balato A; Lembo S; Mattii M; Schiattarella M; Marino R; De Paulis A; Balato N; Ayala F
    Exp Dermatol; 2012 Nov; 21(11):892-4. PubMed ID: 23163661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
    Chiricozzi A; Guttman-Yassky E; Suárez-Fariñas M; Nograles KE; Tian S; Cardinale I; Chimenti S; Krueger JG
    J Invest Dermatol; 2011 Mar; 131(3):677-87. PubMed ID: 21085185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of drugs known to trigger psoriasis on HaCaT keratinocytes].
    Cen JP; Zhu KJ; Jin N; Lin AH; Cheng H
    Yao Xue Xue Bao; 2007 Oct; 42(10):1041-4. PubMed ID: 18229608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IL-33 levels are increased in patients with psoriasis.
    Mitsui A; Tada Y; Takahashi T; Shibata S; Kamata M; Miyagaki T; Fujita H; Sugaya M; Kadono T; Sato S; Asano Y
    Clin Exp Dermatol; 2016 Mar; 41(2):183-9. PubMed ID: 25976154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
    Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
    Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis.
    Meyer N; Zimmermann M; Bürgler S; Bassin C; Woehrl S; Moritz K; Rhyner C; Indermitte P; Schmid-Grendelmeier P; Akdis M; Menz G; Akdis CA
    J Allergy Clin Immunol; 2010 Apr; 125(4):858-865.e10. PubMed ID: 20227751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
    Honma M; Minami-Hori M; Takahashi H; Iizuka H
    J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes.
    Kakurai M; Demitsu T; Umemoto N; Kobayashi Y; Inoue-Narita T; Fujita N; Ohtsuki M; Furukawa Y
    Br J Dermatol; 2009 Dec; 161(6):1232-8. PubMed ID: 19785602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of IL-17F via the induction of IL-6 in psoriasis.
    Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
    Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comano's (Trentino) thermal water interferes with tumour necrosis factor-alpha expression and interleukin-8 production and secretion by cultured human psoriatic keratinocytes: yet other mechanisms of its anti-psoriatic action.
    Dal Pra I; Chiarini A; Pacchiana R; Zumiani G; Zanoni M; Armato U
    Int J Mol Med; 2007 Mar; 19(3):373-9. PubMed ID: 17273783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases.
    Shefler I; Pasmanik-Chor M; Kidron D; Mekori YA; Hershko AY
    J Allergy Clin Immunol; 2014 Jan; 133(1):217-24.e1-3. PubMed ID: 23768573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis.
    Wolk K; Witte E; Warszawska K; Schulze-Tanzil G; Witte K; Philipp S; Kunz S; Döcke WD; Asadullah K; Volk HD; Sterry W; Sabat R
    Eur J Immunol; 2009 Dec; 39(12):3570-81. PubMed ID: 19830738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice.
    Kumari S; Bonnet MC; Ulvmar MH; Wolk K; Karagianni N; Witte E; Uthoff-Hachenberg C; Renauld JC; Kollias G; Toftgard R; Sabat R; Pasparakis M; Haase I
    Immunity; 2013 Nov; 39(5):899-911. PubMed ID: 24211183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid.
    Balato A; Schiattarella M; Lembo S; Mattii M; Prevete N; Balato N; Ayala F
    Arch Dermatol Res; 2013 Apr; 305(3):255-62. PubMed ID: 23435685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of IL -9 and IL-33 in mast cells.
    Sabatino G; Nicoletti M; Neri G; Saggini A; Rosati M; Conti F; Cianchetti E; Toniato E; Fulcheri M; Caraffa A; Antinolfi P; Frydas S; Pandolfi F; Potalivo G; Galzio R; Conti P; Theoharides TC
    J Biol Regul Homeost Agents; 2012; 26(4):577-86. PubMed ID: 23241108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor II induces interleukin-6 expression via NFkappaB activation in psoriasis.
    Kwon YW; Jang ER; Lee YM; Kim YS; Kwon KS; Jang HS; Oh CK; Kim KW
    Biochem Biophys Res Commun; 2000 Nov; 278(2):312-7. PubMed ID: 11097836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
    Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
    Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.